For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your cookie settings, we'll assume you’re happy with this.
Our RabMAb? technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies.
Our patents cover, inter alia, rabbit fusion partners, rabbit hybridomas, and methods of producing rabbit monoclonal antibodies (US 7,429,487; US 4,292,878; US 7,732,168; US 8,062,867; US 8,367,408; US 9,328,333).